A new gene mutation, DUOX2, may cause a type of familial thyroid cancer, according to study results published in Cancer Research.
While there have been increases in the amount of thyroid cancer cases detected, there is still work for oncologists to do – namely to ensure there is adequate evaluation of the disease at diagnosis.
Machine learning of ultrasound scans could provide a preliminary method of screening for thyroid cancer.
Genetic profiles of thyroid cancer shed light on molecular mechanisms.
Researchers look at how mutation status can influence responses to targeted therapy in thyroid cancer.
Most recently, the FDA approved cabozantinib for the treatment of HCC, but this drug has a history.
In late 2015, the American Thyroid Association (ATA) changed guideline recommendations trying to rein in overly aggressive treatment of thyroid cancers that are low risk, offering the choice of hemithyroidectomy as an alternative to total thyroidectomy in these patients. In participating hospitals, the rates of hemithyroidectomy went up.
A new orally active inverse agonist of estrogen-related receptor gamma (ERRү) called DN200434 shows promise with regard to the diagnosis and treatment of anaplastic thyroid cancer.
Alan N. Peiris, MD spoke with ONCOLOGY about guidelines and strategies for treating patients who have had thyroid cancer.
Researchers examined several studies of patients with Graves' Disease to see the prevalence of thyroid cancer in this population.